Importance of chemical reduction in plasma and serum homocysteine analysis

Clinical Chemistry

Volumn 54, Issue 6, 2008, Pages 1085-1086

  Ueland, Per Magne ^a  

^a UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CYSTEINE; DISULFIDE; HOMOCYSTEINE;

BLOOD LEVEL; BLOOD SAMPLING; CARDIOVASCULAR RISK; FLUORESCENCE; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MASS SPECTROMETRY; NONHUMAN; REACTION ANALYSIS; REDUCTION; RISK ASSESSMENT; SHORT SURVEY;

HOMOCYSTEINE; HUMANS; OXIDATION-REDUCTION; PLASMA; SERUM;

EID: 44849100547     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2007.100438     Document Type: Short Survey

References (6)

1. Ueland PM, Helland S, Broch O-J, Schanche J-S. Homocysteine in tissues of the mouse and rat. J Biol Chem 1984;259:2360-4.
2. Ueland PM, Refsum H. Plasma homocysteine, a risk factor for vascular disease: Plasma levels in health, disease, and drug therapy. J Lab Clin Med 1989;114:473-501.
3. Refsum H, Smith AD, Ueland PM, Nexo E, Clarke R, McPartlin J, et al. Facts and recommendations about total homocysteine determinations: an expert opinion. Clin Chem 2004;50:3-32.
4. Ueland PM, Clarke R. Homocysteine and cardiovascular risk: Considering the evidence in the context of study design, folate fortification, and statistical power. Clin Chem 2007;53:807-9.
5. Ueland PM, Midttun O, Windelberg A, Svardal A, Skålevik R, Hustad S. Quantitative profiling of folate and one-carbon metabolism in large-scale epidemiological studies by mass spectrometry. Clin Chem Lab Med 2007;45:1737-45.
6. Ueland PM. Homocysteine species as components of plasma redox thiol status. Clin Chem 1995;41:340-2.